why choose us

First received: July 19, 2022

Clinical Trial: Alirocumab in Patients with Sepsis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Sepsis

Study Type: INTERVENTIONAL


Official Title: PCSK9 and Lipid Metabolism in Sepsis (PALMS) : a Two-center, Phase 1b Randomized, Placebo-controlled, Double-blind, Clinical Trial of Alirocumab in Patients with Sepsis

Brief Summary: The purpose of this study is to determine whether the drug alirocumab, which may lower cholesterol, can reduce the amount of inflammation caused by an infection that has caused either low blood pressure or difficulty breathing.Participants will be randomized to receive a single IV infusion of alirocumab or a placebo.

Read more